Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.88
-0.02 (-0.29%)
Dec 5, 2025, 4:00 PM EST - Market closed
Cartesian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 179 | 461 | 107 | - | - |
| Market Cap Growth | -59.89% | 330.61% | - | - | - |
| Enterprise Value | 48 | 256 | 123 | - | - |
| Last Close Price | 6.88 | 17.91 | 20.68 | - | - |
| PS Ratio | 162.87 | 11.84 | 4.12 | - | - |
| PB Ratio | - | -67.74 | -0.77 | - | - |
| EV/Sales Ratio | 44.11 | 6.58 | 4.75 | - | - |
| Debt / Equity Ratio | -0.35 | -2.06 | -0.08 | 0.40 | 0.18 |
| Debt / EBITDA Ratio | - | - | - | 2.01 | - |
| Asset Turnover | 0.00 | 0.11 | 0.11 | 1.26 | - |
| Quick Ratio | 10.44 | 9.29 | 1.26 | 5.76 | 6.38 |
| Current Ratio | 10.67 | 9.43 | 1.33 | 5.91 | 6.42 |
| Return on Equity (ROE) | - | - | - | 70.21% | - |
| Return on Assets (ROA) | -12.67% | -6.00% | -19.75% | 10.35% | - |
| Return on Capital (ROIC) | - | - | -3021.69% | 12.98% | - |
| Return on Capital Employed (ROCE) | -23.40% | -8.60% | -31.40% | 10.30% | -54.70% |
| Earnings Yield | -26.82% | -16.80% | -205.34% | - | - |
| FCF Yield | -38.51% | -7.11% | -48.01% | - | - |
| Buyback Yield / Dilution | -110.93% | -235.72% | -6.33% | -27.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.